title: Regression and wound healing after excimer laser PRK: a histopathological study on human corneas.
abstract: BACKGROUND
  The results of excimer laser PRK are promising as more than 80% of eyes with up to -6.0 diopters of attempted correction have refractive results within 1.0 diopter of emmetropia. However, throughout the dioptric range some unexpected results have been observed with individual patients showing an aggressive wound healing response with excessive myopic regression and severe corneal haze. Unfortunately, only limited data are available about the cellular and extracellular responses in human corneas after PRK and this information is important to establish adequate postoperative pharmaceutical treatment.
  
  
  METHODS
  We made a histopathological and immunohistochemical study on 20 human corneal samples from patients with severe corneal haze and myopic regression. The indirect immunofluorescence method was used for demonstration of collagen types I, III, IV laminin, chondroitin sulphate, dermatan sulphate, and keratin.
  
  
  RESULTS
  All corneal specimens showed a hyperplastic epithelium. Histologically, most samples (16/20) showed mainly a loose lamination of extracellular material which could be identified as collagen type IV. The remaining four samples had newly synthesised collagen type III.
  
  
  CONCLUSIONS
  Our histopathological results indicate that corneal wound healing after excimer laser PRK varies among individuals. In some people epithelial basement proteins, such as collagen type IV, are the main wound healing products, whereas in others mainly collagen type III is found postoperatively, which does not effect the synthesis of collagen type IV. This suggests the need for individually-tailored postoperative pharmaceutical treatment regimens.
authors.affiliation: University Eye Clinic, University of Regensburg, Germany.
authors.forename: C P
authors.initials: CP
authors.lastname: Lohmann
authors.forename: A
authors.initials: A
authors.lastname: Patmore
authors.forename: D
authors.initials: D
authors.lastname: O'Brart
authors.forename: U
authors.initials: U
authors.lastname: Reischl
authors.forename: C
authors.initials: C
authors.lastname: Winkler Mohrenfels
authors.forename: J
authors.initials: J
authors.lastname: Marshall
mesh_terms: D002809:Chondroitin Sulfates / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D003315:Cornea / Q000378:metabolism / Q000601:surgery / Q000648:ultrastructure*; D003318:Corneal Opacity / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D003871:Dermatan Sulfate / Q000378:metabolism; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007633:Keratins / Q000378:metabolism; D007797:Laminin / Q000378:metabolism; D054018:Lasers, Excimer; D009216:Myopia / Q000209:etiology / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D018903:Photorefractive Keratectomy / Q000009:adverse effects*; D014945:Wound Healing
chemical_list: D007797:Laminin; D003871:Dermatan Sulfate; D007633:Keratins; D002809:Chondroitin Sulfates; D003094:Collagen